The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Lab Study Suggests Zinc May Worsen Rheumatoid Arthritis

Lab Study Suggests Zinc May Worsen Rheumatoid Arthritis

January 22, 2022 • By Marilynn Larkin

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Zinc supplementation may exacerbate rheumatoid arthritis (RA), new laboratory data suggest.

You Might Also Like
  • Rheumatoid Arthritis, Periodontal Disease Link Suggests Benefits in Behavioral Change
  • Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis
  • Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome

In monocytes from patients with RA, researchers found high concentrations of intracellular zinc, which regulates immune responses by affecting signaling pathways, according to a report in Science Signaling.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

They also found increased expression of Zip8, a zinc-specific importer, in peripheral and synovial monocytes of patients with RA and zinc-mediated metabolic shift. These shifts are “closely associated with enhanced proinflammatory cytokines,” Dr. Won-Woo Lee of Seoul National University College of Medicine tells Reuters Health by email.

“Among 14 zips, zip8 expression was uniquely increased in peripheral and synovial monocytes,” Dr. Lee says. “Zip8-mediated zinc influx in these cells was important for the inflammatory response, such as the production of the proinflammatory cytokine interleukin [IL] 1beta.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Further, he says, “We found that zinc acts as a regulator of the mTORC1/S6K signaling pathway involved in the metabolic shift that was required for increased IL-1beta production. In monocytes from RA patients [compared with controls], the expression of zip8 and the activity of mTORC1/S6K were enhanced, and Zip8 expression correlated with more severe RA, suggesting that the zinc-mediated metabolic shift in monocytes is associated with clinical parameters of RA patients.”

From a potential treatment perspective, he says, “Considering the biological importance of zinc in our body, rather than reducing the systemic zinc level, it is necessary to develop a small molecule inhibitor that can block zinc influx by binding to zip8, or a strategy that can specifically inhibit only the expression of Zip8.”

John Hardin, MD, professor emeritus in medicine in the Department of Microbiology and Immunology and Orthopedic Surgery at Montefiore Medical Center, New York, commented on the study in an email to Reuters Health.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“This study raises the possibility that … people with an autoimmune disease, such as RA [may] be harmed by increased exposure to zinc,” he says. “It seems urgently important to explore this possibility, given the very large number of people who consume over-the-counter zinc supplements.”

“This work [may] be expanded to studies in whole animals and even humans who are exposed to, or deprived of, zinc in terms of alterations in intracellular signaling, expression of inflammatory biomarkers, and disease expression,” he says. “For example, there are some reports of zinc promoting osteoarthritis, a disease in which IL-1 is thought to be an important mediator. The mechanistic insights provided by the present study will enable future studies focused on such questions.”

Pages: 1 2 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: dietary supplement, Rheumatoid Arthritis (RA), zinc

You Might Also Like:
  • Rheumatoid Arthritis, Periodontal Disease Link Suggests Benefits in Behavioral Change
  • Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis
  • Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome
  • Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)